Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Tracy Stockley

29PUBLICATIONS
108CO-AUTHORS
Bioinformatic methods developmentPredictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

Sort by Publication Date:
|May 13, 2026
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project.

|Oct 05, 2025
Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18-gene panel.

Elisabeth Spenard, Cristina Mitric, Melanie Care

|Mar 26, 2025
Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in Canada.

Meghan J Walker, Anna Neely, Antonis C Antoniou

|Aug 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center Experience.

Shelley Kuang, Kaitlin Chen, Sachin Sayal

|Jun 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities.

Meghan J Walker, Kristina M Blackmore, Amy Chang

|Nov 28, 2023
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma.

Cha Len Lee, Grainne M O'Kane, Warren P Mason

Pageof 5

Frequent Collaborators

5 joint publications

Jennifer D Brooks

5 joint publications

Michel Dorval

4 joint publications

Bartha Maria Knoppers

4 joint publications

Jacques Simard

4 joint publications

Raymond H Kim

3 joint publications

Nora Pashayan

3 joint publications

Tim Carver

3 joint publications

Ming Sound Tsao

3 joint publications

Harriet Feilotter

3 joint publications

Meghan J Walker

Frequent Collaborators

5 joint publications

Jennifer D Brooks

5 joint publications

Michel Dorval

4 joint publications

Bartha Maria Knoppers

4 joint publications

Jacques Simard